●K13 NEWS / EDITION21/11/2026DIGITAL NEWSPAPERContact
K13 NEWS / WORLD
WORLD / K13 NEWS

Judge Approves $7.25bn Bayer Settlement Over Cancer Claims for Roundup

A Missouri judge has approved a $7.25 billion settlement between Bayer and plaintiffs alleging its weedkiller Roundup causes cancer. The deal resolves nearly all current and future U.S. claims, with critics saying it undermines victims' legal rights. The ruling follows a Supreme Court decision limiting failure-to-warn lawsuits under state law.

Judge Approves $7.25bn Bayer Settlement Over Cancer Claims for Roundup

A Missouri federal judge on Friday approved a $7.25 billion settlement between German chemical company Bayer and individuals who allege they developed cancer after using its herbicide Roundup.

Background of the Litigation

Bayer faced approximately 65,000 claims in U.S. state and federal courts from people asserting that exposure to Roundup led to their diagnosis of cancer—either at home or on the job. These claims have spanned nearly a decade, placing significant financial and reputational strain on the company since it acquired Monsanto in 2018 for $63 billion.

The settlement, announced in February, aims to resolve both existing and future lawsuits related to Roundup use across the United States. It follows earlier attempts: in 2020, Bayer settled about half of its litigation with a $10.9 billion payment; however, a proposed $1.25 billion resolution for pending cases was rejected by courts.

Legal Rationale Behind Approval

Judge Timothy Boyer of St Louis County Court found the settlement "fair, reasonable and adequate." He overruled objections that individual payouts were insufficient—particularly because those who previously settled received higher compensation—and stated that delaying payments could force victims, including those with terminal diagnoses, to wait an indeterminate number of years before receiving any financial relief.

The decision comes five months after the U.S. Supreme Court issued a 7-2 ruling in favor of Bayer, overturning a $1.25 million jury award for Missouri man John Durnell, whose non-Hodgkin lymphoma was attributed to long-term exposure to glyphosate—the active ingredient in Roundup.

In its majority opinion, the court held that federal pesticide regulations preclude failure-to-warn claims brought under state law—effectively weakening a central legal argument used by many plaintiffs throughout their litigation efforts.

Company and Legal Positions

Bayer has consistently maintained that Roundup and its primary component, glyphosate, are safe based on decades of scientific studies showing no causal link between glyphosate use and cancer. The company’s CEO, Bill Anderson, stated: "The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation."

Christopher Seeger, representing several plaintiff groups, said the Supreme Court decision narrows victims’ ability to pursue legal claims. He added: "We look forward to getting this relief into the hands of all Roundup victims as quickly as possible."

Ongoing Legal Challenges

The settlement does not resolve all outstanding cases. Bayer has indicated that about 200 lawsuits remain active in federal courts. These cases are still being litigated, and the company says they have been strengthened by the recent U.S. Supreme Court ruling.

No official confirmation or independent verification was provided regarding medical causality between glyphosate exposure and cancer diagnoses. The report relies solely on public statements from parties involved and court rulings, without confirming individual health outcomes or scientific evidence linking Roundup to specific cancers.

← FRONT PAGE